Johnson Emily P, Monsour Robert, Hafez Osama, Kotha Rohini, Ackerman Robert S
Herbert Wertheim College of Medicine, Florida International University, Miami, FL 33199, USA.
Morsani College of Medicine, University of South Florida, Tampa, FL 33602, USA.
Clin Pract. 2024 May 17;14(3):906-914. doi: 10.3390/clinpract14030071.
The Revised Cardiac Risk Index (RCRI) and the American College of Surgeons (ACS) National Surgical Quality Improvement Program (NSQIP) preoperative risk assessment tools are the most widely used methods for quantifying the risk of major negative perioperative cardiac outcomes that a patient may face during and after noncardiac surgery. However, these tools were created to include as wide a range of surgical factors as possible; thus, some predictive accuracy is sacrificed when it comes to certain surgical subpopulations. In this review, we explore the various surgical oncology patient populations for whom these assessment tools can be reliably applied and for whom they demonstrate poor reliability.
修订后的心脏风险指数（RCRI）和美国外科医师学会（ACS）国家外科质量改进计划（NSQIP）术前风险评估工具是用于量化患者在非心脏手术期间及术后可能面临的围手术期重大不良心脏结局风险的最广泛使用的方法。然而，这些工具旨在纳入尽可能广泛的手术因素；因此，在某些手术亚组方面，会牺牲一些预测准确性。在本综述中，我们探讨了这些评估工具可可靠应用的各种外科肿瘤患者群体以及显示出可靠性较差的患者群体。
